Tris-base buffer: a promising new inhibitor for cancer progression and metastasis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Tris-base buffer: a promising new inhibitor for cancer progression and metastasis

Published:2017-05-29 Issue:7 Volume:6 Page:1720-1729
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Ibrahim-Hashim Arig¹^ORCID,Abrahams Dominique¹,Enriquez-Navas Pedro M.¹,Luddy Kim¹,Gatenby Robert A.²³,Gillies Robert J.¹³

Affiliation:

1. Department of Cancer Imaging and Metabolism; H. Lee Moffitt Cancer Center; Tampa Florida

2. Department of Integrated Mathematical Oncology; H. Lee Moffitt Cancer Center; Tampa Florida

3. Department of Radiology; H. Lee Moffitt Cancer Center; Tampa Florida

Funder

National Institute for Health Research

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Reference19 articles.

1. Evidence-based support for the use of proton pump inhibitors in cancer therapy;Fais;J. Transl. Med.,2015

2. Vacuolar-type H(+)-ATPases are functionally expressed in plasma membranes of human tumor cells;Martinez-Zaguilan;Am. J. Physiol.,1993

3. Regulation of tumor pH and the role of carbonic anhydrase 9;Swietach;Cancer Metastasis Rev.,2007

4. Regulatory mechanisms in carbohydrate metabolism. III. Limiting factors in glycolysis of ascites tumor cells;Wu;J Biol Chem.,1959

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antibodies toward Na+,HCO3–-cotransporter NBCn1/SLC4A7 block net acid extrusion and cause pH-dependent growth inhibition and apoptosis in breast cancer;British Journal of Cancer;2024-02-03

2. Redox Chemistry of “Neglected Copper‐Tris” Complex in Presence of Ascorbic Acid and O₂;ChemistrySelect;2024-01-22

3. Targeting the lactic acid metabolic pathway for antitumor therapy;Molecular Therapy - Oncolytics;2023-12

4. How protons pave the way to aggressive cancers;Nature Reviews Cancer;2023-10-26

5. In Situ Insonation of Alkaline Buffer Containing Liposomes Leads to a Net Improvement of the Therapeutic Outcome in a Triple Negative Breast Cancer Murine Model;Advanced Healthcare Materials;2023-09-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3